Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers
Johns Hopkins University · Johns Hopkins Medicine · +1 more institution
Abstract
In the context of pancreatic cancer, metastasis remains the most critical determinant of resectability, and hence survival. The objective of this study was to determine whether Hedgehog (Hh) signaling plays a role in pancreatic cancer invasion and metastasis because this is likely to have profound clinical implications. In pancreatic cancer cell lines, Hh inhibition with cyclopamine resulted in down-regulation of snail and up-regulation of E-cadherin, consistent with inhibition of epithelial-to-mesenchymal transition, and was mirrored by a striking reduction of in vitro invasive capacity (P
Citation impact
- FWCI
- 25.02
- Percentile
- 100%
- References
- 28
Authors
13- GFGeorg FeldmannCorresponding
Johns Hopkins University, Johns Hopkins Medicine, Cancer Research Center
- SDSurajit Dhara
Johns Hopkins University, Johns Hopkins Medicine, Cancer Research Center
- VFVolker Fendrich
- DBDjahida Bedja
- RMRobert M. Beaty
Johns Hopkins University, Johns Hopkins Medicine, Cancer Research Center
Topics & keywords
- Cyclopamine
- Pancreatic cancer
- Cancer research
- GLI1
- Metastasis
- Hedgehog signaling pathway
- Carbenoxolone
- Epithelial–mesenchymal transition
- Good health and well-being